InsidersTradesSigma
Grand Pharmaceutical Group Ltd.: directors' dealings · Hong Kong · HKEX
HKEX:grand-pharmaceutical-group-ltdHK·HKEXMcap 20.2Bn€Healthcare
Explore the full management transaction log of Grand Pharmaceutical Group Ltd., a listed issuer based in Hong Kong. Shares trade on HK HK, under the supervision of HKEX. Operating in the Healthcare sector, Grand Pharmaceutical Group Ltd. has logged 3 public disclosures. Market capitalisation: €20.2bn. The latest transaction was filed on 22 April 2026 — Purchase. Among the most active insiders: Tang Weikun. Every trade is openly available.
3
Insider Decl.
0
Thresholds
€119,833
3 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
5.78 €
Analyst consensus
4 analystsStrong buy
11.70 €Target 11.89 €(+106%)12.00 €
Income statement
Revenue12.28 Bn€
Gross profit6.78 Bn€55% margin
Net income1.24 Bn€10.1% margin
Valuation
PER (trailing)16.5x
PER (forward)9.0x
P/Book1.2x
Beta0.74
Balance sheet & cash
Market cap20.24 Bn€
Total debt4.72 Bn€
Free Cash Flow127.4 M€
Debt / Equity28%
Profitability & ownership
ROE7.4%
ROA4.2%
% insiders67.6%
% institutions17.0%
Last declaration on 22 April 2026
Declarations3 total
Executives●Purchase12HKEX
€35,29450,000 shares@ €0.70590.0002% mcap45.0% of flow
ShareXHKG
HKEX:DA20260422E00402·
Ideal exit: 17 Jan 2027 (T+270)
Executives●Purchase14HKEX
€43,19360,000 shares@ €0.71990.0002% mcap55.0% of flow
ShareXHKG
HKEX:DA20260327E00255·
Ideal exit: 22 Dec 2026 (T+270)
3 of 3 declarations